Biopharmaceutical News and Research

RSS
Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Research reveals clues to how a molecule improves appearance of surgery scars

Research reveals clues to how a molecule improves appearance of surgery scars

SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production

SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities

Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities

Drugmakers’ spending on stock, dividends and executive pay exceeds research, democrats say

Drugmakers’ spending on stock, dividends and executive pay exceeds research, democrats say

Nikalyte Announces New Partnership with Life Science Group Calibre Scientific

Nikalyte Announces New Partnership with Life Science Group Calibre Scientific

WEHI collaborates with Boehringer Ingelheim to develop novel anti-cancer therapeutics

WEHI collaborates with Boehringer Ingelheim to develop novel anti-cancer therapeutics

SP launches SP Hull LyoStar® 4.0 R&D freeze dryer to enhance speed to market in drug development

SP launches SP Hull LyoStar® 4.0 R&D freeze dryer to enhance speed to market in drug development

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

Insilico Medicine receives $255 million to develop AI and drug discovery capabilities

Insilico Medicine receives $255 million to develop AI and drug discovery capabilities

Study determines the mechanism behind respiratory inflammation and finds effective treatment

Study determines the mechanism behind respiratory inflammation and finds effective treatment

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

PhoreMost appoints Christian Dillon as Vice President of Biology

PhoreMost appoints Christian Dillon as Vice President of Biology

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study